InvestSMART

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Ceasing to be a substantial holder 3 Aug 2021 4:42PM $1.280 $0.013 fallen by 98.98%
$18 Opthea's OPT-302 Granted Fast-Track for wet AMD 6 Jul 2021 8:19AM $1.260 $0.013 fallen by 98.97%
$18 Change in substantial holding 23 Jun 2021 6:04PM $1.280 $0.013 fallen by 98.98%
$18 Change in substantial holding 22 Jun 2021 4:43PM $1.305 $0.013 fallen by 99%
$18 Cleansing Notice 22 Jun 2021 8:29AM $1.330 $0.013 fallen by 99.02%
$18 Application for quotation of securities - OPT 22 Jun 2021 8:23AM $1.330 $0.013 fallen by 99.02%
$18 Change in substantial holding 22 Jun 2021 8:18AM $1.330 $0.013 fallen by 99.02%
$18 Change in substantial holding 21 Jun 2021 5:27PM $1.330 $0.013 fallen by 99.02%
$18 Proposed issue of securities - OPT 21 Jun 2021 4:28PM $1.330 $0.013 fallen by 99.02%
$18 Opthea Appoints Company Secretary and VP of Finance 15 Jun 2021 8:17AM $1.415 $0.013 fallen by 99.08%
$18 Initial Director's Interest Notice-JH 7 Jun 2021 12:02PM $1.440 $0.013 fallen by 99.10%
$18 Initial Director's Interest Notice-JR 7 Jun 2021 12:01PM $1.440 $0.013 fallen by 99.10%
$18 Director Appointment/Resignation 2 Jun 2021 8:16AM $1.530 $0.013 fallen by 99.15%
$18 Change in substantial holding 25 May 2021 8:21AM $1.470 $0.013 fallen by 99.12%
$18 Becoming a substantial holder 28 Apr 2021 8:16AM $1.450 $0.013 fallen by 99.10%
$18 Opthea Company Secretary Resignation 6 Apr 2021 8:27AM $1.560 $0.013 fallen by 99.17%
$18 Opthea Receives FDA Waiver for Pediatric Study Plan 31 Mar 2021 9:01AM $1.430 $0.013 fallen by 99.09%
$18 Change in substantial holding 26 Mar 2021 8:23AM $1.595 $0.013 fallen by 99.18%
$18 Appendix 2A Update 25 Mar 2021 3:59PM $1.585 $0.013 fallen by 99.18%
$18 Cleansing Notice 25 Mar 2021 8:47AM $1.640 $0.013 fallen by 99.21%
$18 Appendix 2A 25 Mar 2021 8:43AM $1.640 $0.013 fallen by 99.21%
$18 Proposed issue of Securities - OPT 25 Mar 2021 8:25AM $1.640 $0.013 fallen by 99.21%
$18 Opthea Treats First Patient in Phase 3 Trials of OPT-302 15 Mar 2021 8:32AM $1.540 $0.013 fallen by 99.16%
$18 Opthea to Present at Oppenheimer Healthcare Conference 10 Mar 2021 8:32AM $1.490 $0.013 fallen by 99.13%
$18 Change of Director's Interest Notice - MS 5 Mar 2021 5:47PM $1.500 $0.013 fallen by 99.13%

426 - 450 of 733 results

Page 18 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.